Original Articles Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 15, 2000; 6(4): 501-507
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.501
Study on relationship of nitric oxide, oxidation, peroxidation, lipoperoxidation with chronic chole-cystitis
Jun-Fu Zhou, Dong Cai, Cheng-Hong Peng, Yang-Hai Yu, The Second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou 310009, Zhejiang Province, China
You-Gen Zhu, Jin-Lu Yang, The People’s Hospital of Jinhua City, Jinhua 321000, Zhejiang Province, China
Jun-Fu Zhou, M.D, male, born on 1945-03-07 in Hangzhou, Zhejiang Province, graduated from Zhejiang Medical University, having 150 papers published and having won 10 Advanced Prizes in Science and Technology from Zhejiang Province People’s Government and PLA
Author contributions: All authors contributed equally to the work.
Correspondence to: Prof. Jun-Fu Zhou, The Second Affiliated Hospital of Medical College of Zhejiang University, 68 Jiefang Road, Hangzhou 310009, Zhejiang Province, China
Telephone: +86-571-778-3768 or 605-2515 Fax: +86-571-721-3864
Received: February 12, 2000
Revised: February 26, 2000
Accepted: March 5, 2000
Published online: August 15, 2000

Abstract

AIM: To study relationship of injury induced by nitric oxide, oxidation, peroxidation, lipoperoxidation with chronic cholecystitis.

METHODS: The values of plasma nitric oxide (P-NO), plasma vitamin C (P-VC), plasma vitamin E (P-VE), plasma β-carotene (P-β-CAR), plasma lipoperoxides (P-LPO), erythrocyte superoxide dismutase (E-SOD), erythrocyte catalase (E-CAT), erythrocyte glutathione peroxidase (E-GSH-Px) activities and erythrocyte lipoperoxides (E-LPO) level in 77 patients with chro nic cholecystitis and 80 healthy control subjects were determined, differences of the above average values between t he patient group and the control group and differences of the average values bet ween preoperative and postoperative patients were analyzed and compared, linear regression and correlation of the disease course with the above determination values as well as the stepwise regression and correlation of the course with th e values were analyzed.

RESULTS: Compared with the control group, the average values of P-NO, P-LPO, E-LPO were significantly increased (P < 0.01), and of P-VC, P-VE, P-β-CAR, E-SOD, E-CAT and E-GSH-Px decreased (P < 0.01) in the patient group. The analysis of the lin ear regression and correlation s howed that with prolonging of the course, the values of P-NO, P-LPO and E-LPO in the patients were gradually ascended and the values of P-VC, P-VE, P-β-CAR, E-SOD, E-CAT and E-GSH-Px descended (P < 0.01). The analysis of the stepwise regression and correlation indicated that the correlation of the course with P-NO, P-VE and P-β-CAR values was the closest. Compared with the preoperative patients, the average values of P-NO, P-LPO and E-LPO were significantly decre ased (P < 0.01) and the average values of P-VC, E-SOD, E-CAT and E-GSH-Px in postoperative pa tients increased (P < 0.01) in postoperative patients. But there was no signif icant difference in the average values of P-VE, P-β-CAR preope rative and postoperative patients.

CONCLUSION: Chronic cholecystitis could induce the increase of nitric oxide, oxidation, peroxidation and lipoperoxidation.

Key Words: nitric oxide, oxidation, peroxidation, lipoperoxidation, chronic cholecystitis



INTRODUCTION

Chronic cholecystitis is a frequently encountered disease of the digestive syste m. Some studies point out that in blood of patients with acute cholecystitis the levels of inducible nitric oxide (i NO) and lipoperoxides are markedly incre ased, while the level of vitamin C, the activities of superoxide dismutase and g lutathione enzyme are significantly decreased[1-5]. However, up to now , there has been no reports on the above in patients with chronic cholecystit is. In order to observe the metabolic state of nitric oxide and other free radi cals in patients with chronic cholecystitis, and the degree of injury induced by oxidation, peroxidation, lipoperoxidation due to the chronicity of cholecystiti s, we determined nitric oxide (P-NO), vitamin C (P-VC), vitamin E (P-VE), β-carotene (P-β-CAR) and lipoperoxides (P-LPO) levels in the pla sma as well as superoxide dismutase (E-SOD), catalase (E-CAT), glutathione peroxidase (E-GSH-Px) activity and lipoperoxides (E-LPO) level in the erythrocytes in 77 patients with chronic cholecystitis and 80 healthy controls. We also an alyzed and compared differences of the above average determination values betwee n the patient and the control group, and between preoperative and postoperative patients. Additionally, we analyzed the relationship between the course of the d isease and the above values in the patients by the linear regression and correla tion as well as the stepwise regression and correlation.

SUBJECTS AND METHODS
Subjects

Patients Seventy-seven patients suffering form chronic cholecystitis with gallsto nes who were confirmed diagnostically through abdominoscopy and biopsy in the People’s Hospital of Jinhua City were randomly sampled. Their ages ranged fro m 31 to 69 years (52.4 a ± 10.3 a), and their courses of disease were from 2 to 20 years (5.2 a ± 5.6 a). Of them, 32 were male and 45 were female. No patients had abnormality in the routine examination of blood, urine, feces, ECG and X-rays, and medical history about heart, brain, lung, liver, kidney, diabetes, autoimmune disease, peripheral vascular disease, cataract, tumor, and so on. The gallbladders of all the patients with chronic cholecystitis were removed by abdo minoscopy.

Control Eighty healthy adults confirmed through the comprehensive he alth examination by the 2nd Affiliated Hospital of Zhejiang University were randomly sampled, their ages were from 31 to 70 years (52.7 a ± 9.6 a), and 40 were male and 40 were female. The healthy adults were all normal in the routine examination of blood, urine, feces, ECG and X-rays, with no medical history regarding heart, brain, lung, liver, kidney, cholecystic disease, diabetes, autoimmune disease, peripheral vascular disease, cataract, tumor, etc .

All the patients and the healthy adults had neither exposure to kind of radiation, nor contacted any kind of pesticide and poison. Within a month prior to the study they had not taken any antioxidants such as vitamin C, vitamin E, g inkgo leaf agents, tea-polyphenol etc. There was neither any significant di ffer ence (P > 0.05) between the average age of the patient and the control group as determined by t test, and nor any significant difference (P > 0.05) betw een the gender proportion of the patient and the control group as determined by χ2 test.

Methods

Blood samples Fasting venous blood samples were collected in the morning for all the subjects with heparin sodium as an ant icoagulant. The separated plasma and erythrocytes were stored immediately at 4 °C[6].

Plasma NO (P-NO) level Colloidal aluminium hydroxide without nitrite was used to absorb yellow pigments and to cause protein sedimentation in the plasma. The nitrite in the supernatant, which contained sodium acetate (0.20 mol/L) and sulphanilic acid (3.30 mmol/L), reacted with β-Naphthyla mine and formed a colored product, which was detected spectrophoto-metrically, using sodium nitrite (2.50 μmol/L) as the standard and at a wavelength of 520 nm. The P-NO concentration was expressed in nmol/L[6,7].

Plasma LPO (P-LPO) level Trichloroacetic acid (TCA) solution (20.0 g%, w/v) was used to cause protein sedimentation in the plasma. The protein sediment reacted with thiobarbituric acid (TBA) solution (0.67 g%, w/v) and produced red colored compounds following incubation in a water bath at 100 °C. This was detect ed spectrophotometrically at 532 nm, using tetraethoxypropane (TEP, 5.0 μmol/L) as the standard. The P-LPO concentration was expressed as μmol/L[6,8].

Plasma VC (P-VC) level TCA (5.0 g%, w/v) was used to cause protein sedim entation in the plasma, and ferric trichloride was added to the supernatant. Vit amin C in the supernatant reduced Fe3+ in ferric trichloride to Fe2+. Fe2+, on reacting with ferrocene, produced a colored product which was detected spectrophotometrically at 563 nm, using vitamin C as the standa rd. The P-VC concentration was expressed as μmol/L[6,9] .

Plasma VE (P-VE) level Absolute ethyl alcohol was used to cause protein sedimentation in the plasma and to extract vitamin E. Vitamin E in the supernata nt reduced Fe3+ in ferric trichloride to Fe2+. Fe2+ reacted with ferrocene to form a colored product that was detected spectrophotometrically at 563 nm, using vitamin E as the standard. The P-VE concentration was expressed as μmol/L[6,10].

Plasma β-CAR(P-β-CAR)level A mixture of a bsolute ethyl alcohol and petroleum ether was used to cause protein sedimentati on in the plasma and to extract β-carotene. The petroleum ether extract containing β-carotene was an alyzed colorimetrically, using β-carotene as the standard at a wav elength se tting of 440 nm. The P-β-CAR concentration was expressed as μmol/L[6,11].

Erythrocyte LPO (E-LPO) level A mixture of absolute ethyl alcohol and t richlorom ethane (5 : 3) was used to precipitate hemoglobin (Hb) from a hemolytic solution (HS) of RBC without WBC and platelets. Hb level was determined in the HS. LPO in the extracted solution reacted with TBA-glacial acetic acid solution (1.0 g%, w/v) in a water bath at 100 °C and produced red colored compounds. These were det ected using TEP (5.0 μmol/L) as the standard at 532 nm. The E-LPO concentration was expressed as nmol/g Hb[6,12].

Erythrocyte SOD (E-SOD) activity A mixture of absolute ethyl alcohol and trichloromethane (5:3) was used to precipitate Hb from the HS of RBC without WBC and platelets. Hb level was determined in the HS. Pyrogallol (6.0 mmol/L) au to-oxidized in Tris-HCl buffer (50 mmol/L, pH 8.20), SOD was added to the buff er to inhibit its auto-oxidation and SOD activity was calculated according to t he auto-oxidation rate of pyrogallol and the rate of SOD-inhibited pyrogallol auto-oxidation. The WL of 420 nm was used and the E-SOD activity was indicated as U/g Hb[6,13].

Erythrocyte CAT (E-CAT) activity H2O2 (0.20 mol/ L) was added to phos phate buffer (10 mmol/L, pH 7.0) containing HS of RBC without WBC and platelets.The Hb level was determined in the HS. After a reaction time of 60 s, a s olution of potassium dichromate (0.169 mol/L) and glacial acetic acid (1 : 3) was added to the reacting mixture to stop the reaction, and the reacting mixture was heated for 10 min at 100 °C. Colorimetry was done at 570 nm. The E-CAT activity was indicated as K/g Hb[6,14].

Erythrocyte GSH-Px (E-GSH-Px) activity A mixture of absolute ethyl alc ohol and trichloromethane (5 : 3) was used to precipitate Hb from the HS of RBC without WBC and platelets. Hb level was determined in the HS. GSH-Px in the ext ract catalyzed the reaction of glutathione and 5, 5’Dithiobis-p-nitr obenzoic acid (DTNB) and produced yellow colored compounds which were detected at 422 nm, using glutathione (1.0 mmol/L) as the standard. The E-GSH-Px activity was expressed as U/g Hb[6,15].

Major analytical reagents such as Vitamin C, Vitamin E, β-Carotene , Superoxi de dismutase, Catalase, β-Naphthylamine, 1,2,3-Trihydroxybenzene(pyrogallol),1, 1,3,3-Tetraethoxypropane, 2-Thiobarbituric acid were all purchased from SIGMA CHEMICAL COMPANY, USA; and the other analytical-grade reagents were all procured form China. The main analytical instruments were 721-spectrophotometer and UV-754-spectrophotometer.

Statistic analysis

All data were analyzed with SPSS/8.0 and Statistica/6.0 statistic software u sing Compaq Pentium III/600 computer. Statistical testing methods inc luded unpaired and paired t test and chi square test (χ2 test), linear reg ression and correlation analysis, stepwise regression and correlation analysis, and confidence interval (CI) of 95%. The level of significance of hypothesis testing was P < 0.05 and the power of test (power) > 0.75.

Results

Comparison between the above mentioned determinations in the patien t and the control group

The average values determined for P-NO, P-LPO and E-LPO in the patient group were significantly increased (P < 0.01) with respect to the control, whereas the average values of P-VC, P-VE, P-β -CAR, E-SOD , E-CAT and E-GSH- Px in the patient group were significantly decreased (P < 0.01) (Table 1).

Table 1 Comparison of various determinations between patient group and control group (95%CI, -x±s).
GroupnP-NO nmol/LP-VC µmol/LP-VE µmol/LP-β-CAR µmol/LE-SOD U/g HbE-CAT K/g HbE-GSH-Px U/g HbP-LPOmµmol/LE-LPO nmol/g Hb
Patient77514 ± 14244.3 ± 10.919.1 ± 4.61.35 ± 0.381813 ± 249233 ± 5722.7 ± 4.813.6 ± 1.938.2 ± 7.2
482-54641.8-46.818.0-20.11.26-1.441757-1869220-24621.6-23.813.2-14.036.6-39.8
Control80365 ± 15755.2 ± 12.825.4 ± 5.31.72 ± 0.452057 ± 212309 ± 6127.2 ± 5.511.3 ± 1.729.4 ± 6.7
330-40052.4-58.024.2-26.61.62-1.822010-2104295-32326.0-28.410.9-11.727.9-30.9
t6.22905.73447.94155.55596.61978.05885.45358.00017.9316
P< 0.01< 0.01< 0.01< 0.01< 0.01< 0.01< 0.01< 0.01< 0.01

Comparison between the above mentioned determinations in the preop erative an d the postoperative patients The average values of P-NO, P-LPO and E-LPO in the postoperative patients were significantly decreased (P < 0.01), whereas the average determination values of P-VC, E-SOD, E- CAT and E-GSH-Px in the postoperative patients were significantly increased (P < 0.01) , but there was no significant difference between the average values of P-VE, P-β - CAR in the pre- and postoperative patients (Table 2).

Table 2 Comparison of various determinations between preoperative and postoperative patients (95%CI -x±s).
GroupnP-NO nmol/LP-VC µmol/LP-VE µmol/LP-β-CAR µmol/LE-SOD U/g HbE-CAT K/g HbE-GSH-Px U/g HbP-LPO µmol/LE-LPO nmol/g Hb
Postoperative77514 ± 14244.3 ± 10.919.1 ± 4.61.35 ± 0.381813 ± 249233 ± 5722.7 ± 4.813.6 ± 1.938.2 ± 7.2
482-54641.8-46.818.0-20.11.26-1.441757-1869220-24621.6-23.813.2-14.036.6-39.8
Postoperative77436 ± 13948.5 ± 11.319.3 ± 5.11.34 ± 0.361915 ± 242274 ± 5925.1 ± 5.312.4 ± 1.834.9 ± 6.9
404-46845.9-51.118.1-20.41.26-1.421860-1970261-28723.9-26.312.0-12.833.3-36.5
t*8.97737.53760.87390.57327.981410.80589.54539.238410.3493
P< 0.01< 0.01> 0.05< 0.01< 0.01< 0.01< 0.01< 0.01< 0.01

Linear regression and correlation analysis between the course of disease and the above mentioned values determined in the patients In pace with gradua l prolongi ng of the course of disease in the patients, the values of P-NO, P-LPO, E-LPO in the patients were gradually increased (P < 0.01), the values of P-VC, P-VE, P-β-CAR, E-SOD, E-CAT, E-G SH-Px were gradually decreased (P < 0.01) (Table 3).

Table 3 Linear regression and correlation analysis between the course of disease and the values determined in the patients.
Correlative itemnRegression equationrtrP
Course with P-NO77Y = 368.6527+18.8688X0.71628.8874< 0.01
Course with P-LPO77Y = 11.8836+0.2212X0.69588.3888< 0.01
Course with E-LPO77Y = 31.5301+0.8807X0.63697.1553< 0.01
Course with P-VC77Y = 53.7124-1.1505X0.64957.3982< 0.01
Course with P-VE77Y = 23.3849-0.4532X0.55725.8114< 0.01
Course with P-β-CAR77Y = 1.7887-0.0486X0.74289.6093< 0.01
Course with E-SOD77Y = 2075.87-29.3446X0.62396.9146< 0.01
Course with E-CAT77Y = 282.0238-6.7284X0.72279.0545< 0.01
Course with E-GSH-Px77Y = 28.6710-0.7006X0.72339.0702< 0.01

Stepwise regression and correlation analysis for the course of disease and the a bove-mentioned values determined in the patients Supposing the course of disease in the patients to be y, the determination valu es of P-NO, P-VC, P-VE, P-β-CAR, E-SOD, E-CAT, E-GSH-Px, P- LPO and E-LPO in the patients to be x1, x2, x3, x4, x5, x6, x7, x8 and x9 respectively, after stepwise regression and corre lation, the stepwise regression equation was y = -0.2706 + 0.0203x1 + 0.6844x3-11.3731x4, r = 0.7902, F = 40.4440, P < 0.01. The e quation suggested that the correlation of the course of disease was the closest with the values determined for P-NO, P-VE and P-β-CAR.

DISCUSSION

The metabolic status of nitric oxide and functional status be tween oxidation and antioxidation systems in human body are in close relationship with health[6-10,12-73]. If the metabolism of nitric oxide is abnorm al and the dynamic balance between oxidation and antioxidation is disturbed, free radicals (FRs) concentration will unusua lly increase and a series of FRs chain reactions will pathologically aggravate i n human body. This status can speed senility of human cells, and induce many diseases[6-10,12-73]. Vitamin C (VC), vitamin E (VE) and β-carotene (β-CAR) are the most imp ortant antioxidants in human body, and they play an important role in scavenging superoxide anions (O·2), hydxoy l radic al (·OH), hydroperoxyl radical (HO·2), lipid FRs, lip ox yl FRs, alkyl FRs, alkoxyl FRs, singlet oxygen (1O2), hydrogen peroxide (H2O2) and others, thereby protecting biological membranes a gainst oxidation, peroxidation and lipoperoxidation[6,9,10,44-54,56-69] injury. And they can promote synthesis and stabilization of immunoglobulin in human body and obstruct formation of carcinogens such as nitrosamine[6,9,10,44-54,56-69]. Superoxide dismutase (SOD), catalase (CAT) and glu tathione peroxidase (GSH-Px) are the most important specific antioxidases in hu man body, SOD is able to clean O·2, obstruct and preven t the pathological aggravation of a series of FRs chain reactions induced by O·2 , CAT enables toxic active mass H2O2 to degrad e into non-toxic O2 and H2O, GSH-Px may decompose toxic active mass LPO[6,13-15,29-39,41,42,46-54,56-69]. LPO and its metabolic products such as mal ondialdehyde (MDA), conjugated diene (CD) and others are important poisonous residual products that enable biological membranes to be injured by lipop eroxidation. Marked increase in LPO level in human body can strongly attack DNA, proteins, enzymes, biological membranes and so on, which leads to the lipoperoxidation injury of the biological membranes, etc[5-8,39-43,48-53,62-71]. Nitric oxide (NO) is a neurotransmitter and en dothelium-derived factor that reduces tone of vascular smooth muscle, and disor der of NO metabolism can induce many diseases[6,7,16-28,46-49,55,62-66].

In this study the results that the average values of P-NO, P-LPO and E-LPO in the patient group were significantly higher than those in the control group ( P < 0.01), and that the average values of P-VC, P-VE, P-β-CAR, E-SOD, E-CAT and E-GSH-Px in the patient group were significantly lower than those of the control group (P < 0.01) showed that there was a severe disorder of the NO metabolism and imbalance between oxidation and antioxidation, and there was the pathological aggravation of the oxidation, peroxidation, lipoperoxidation reactions in the bodies of the patients with chronic cholecystitis and galls tones. The causes probably were as follows. The cytokines, particularly interleukin -I (IL-1), which were released out by inflammatory cells such as phagocytes namely lymphocytes, neutrophilic granulocytes, macro-phagocytes in the cholec ystic inflammatory reaction, can activate inducible nitric oxide synthase (iNOS). The iNOS enables NO to be produced excessively in the body of patients, thereby resulting in a significant increase in the P-NO value in the patients[6,7,16-28,46-49,55,62-66]. Excessive NO was diffused into near by tissues and cells, thus furthe r leading to injury of the tissues and cells[6,7,16-28,46-49,55,62-66]. The excess NO can combine with iron ions in heme group, with activated guany late cyclase and lipoperoxidation reaction. The excess NO also inactivated antioxidases such as SOD, CAT, GSH-Px by means of the reaction of NO and hydrosul-fide group (-SH) in the enzymes, which further resulted in marked decrease in SOD, CAT, GSH -Px activi ties and further injured cells and biologic membranes. Excessive NO in the body was able to be speedily oxidated into nitrogen dioxide (NO2). Both NO and NO2 thems elves are extremely active FRs, NO2 was still able to react with the organ ic molecules in cystic bile, and activate the neutrocytes and phagocytes in the cho lecystic focus, thereby releasing out a vast amount of O·2, ·OH, HO·2, and H2O2 etc. Meanwhile, the phagocytes such as polymorphonuclear leukocyte were speedily activated, and a large number of O·2, ·OH, HO·2 etc were released out, and continuously got into the blood stream i n the patients, thereby inducing the pathological aggravation of a series of FRs c hain reactions[6,7,16-28,46-49,55,62-66].

It must be stressed that excessive NO was capable of reacting speedily with O·2, thereby forming another kind of free radical, i.e. sup erox ide nitroso free radical (ONOO-) which possessed still more strong oxidative properties. ONOO- can further attack and injure the various cells in the body, and deactivate the antioxidases such as SOD, CAT and GSH-Px. Excess NO and NO2 in hu man body injured DNA by way of the deamination of the base and the chain scission[6,7,46-49,55,62-66]. So, on one hand the P-NO level in the body of patients was significantly increased, and on the other hand the body had no choice but to put to good use a great quantity of antioxidants and antioxidases in the body so as to catch and clear these excess O·2, ·OH, HO2· and others [6-10,12-73], which resulted in significant decrease of the levels of P-VC, P-VE, P-β-CAR and the act ivities of E-SOD, E-CAT, E-GSH-Px in the patients. Besides the gallbladder calculi such as bilirubin, cholesterol and other organic substances themselves also produce a large number of FRs[2-5,29,34,35,70-78].

NO2 is a very active catalyst, and NO2 can aggravate lipoperoxidation of the polyunsaturated fatty acids (PUFAs) through hydrogen-extractive process. The excess NO, NO2, O·2, ·OH, HO·2 also can attack upon directly PUFAs, aggra vate significantly the lipoperoxidation, thereby resulting i n a large number of PUFAs which get lipoperoxidated, and subsequently form LPO. With the addition of the significant reduction in th e synthesis or regeneration of GSH-Px decomposing LPO, and the marked lose of the GSH Px activity, it goes without saying that finally th is status resulted in significant increase of P-LPO and E-LPO levels[6,7,46-49,51,52,55,62-66].

In general most anti-oxidative vitamins such as VC, VE, β-CAR, etc, must be acquired from dietary sources because they cannot be synthesized in the body. It is generally recognized that the chronic chole cystitis patients have poor appetite because their diets are controlled, and digestion of VC, specially digestion of fat-soluble vitamins such as VE and β-CAR, markedly reduced. And the anti-oxidative vitamin-poor diets cannot provide sufficient free radical scav engers to keep the balance between oxidation and antioxidation. For this reason, the values of P-VC, P-VE, P-β-CAR in the bodies of the patients were further significantly decreased[6,9,10,47-54,56-68].

In this study the average values of P-NO, P-LPO and E-LPO in the pos toperative patients were significantly decreased, the average values of P-VC, E-SOD, E-CAT, E-GSH-Px were significantly increased, but there was no significant difference in the average values of P-VE and P-β-CAR between the preoperative and postoperative patients. The findings showed that the series of FRs chain reactions in the body of patients were marked lysis, and the dynamic balance between oxidation and antioxidation, obtained resumption to a very marked degree because of the elimination of inflammatory focus after operati on. However, before the compensation of common bile was established the absorpti on of fats and lipids was still limited, thus the absorption of fat-solubl e VE and β-CAR obviously reduced[6,9,10,47-54,56-68]. Therefore, the normal levels of P-VE, P-β-CAR in the patients were diffi cult to be resumed shortly after operation.

In this study there was the linear correlation between the course of disease and the above determined values, specially the stepwise correlation with the course with P-NO, P-VE, P-β-CAR values was the closest. This st atus suggested t hat in chronic cholecystitis, a large amount of NO p roduced by iNOS induced and activated by the long-time infection and stimulatio n of the calculi in gallbladder provoked the pathological aggravation of a series of FRs chain reactions[2-5,16-29,34,35,46-54,56-78]. As a result, the patients with chronic cholecystitis over a long time were in the state of serious imbalance between oxidation and antioxidation as well as injuries induced by oxidation, peroxidation and lipoperoxidation[2-5,29,34,35,70-78]. The findingss also sho wed that the metabolic status of nitric oxide and the changes in vitamin E and β-carotene levels in the body played an important part in chronic cholecystitis. Therefore, the above values, particularly the dynamic determination of P-NO, P-VE and P-β-CAR values, to a great degree, contribute to wards monitoring the condition and course in patients with chronic cholecystitis.

We think that in treating preoperative and postoperative patients with chronic cholecystitis with suitable dosage of antioxidants such as vitamin C , vitamin E, β-carotene, ginkgo leaf agents, tea-polyphenol daily to the patients may alleviate the injuries induced by oxida tion, peroxidation and lipoperoxidation.

Footnotes

The item of science and technology research plans of Zhejiang Province (No 1999-2-121)

Edited by Zhou XH proofread by Mittra S

References
1.  Sänger P, Schneider H, Hanisch E. [Nonadrenergic noncholinergic regulation of gallstone containing and gallstone free human gallbladders]. Zentralbl Chir. 1997;122:418-424.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Pomelov VS, Zhumalilov ZhSh, Korotkina RN, Karelin AA. [Glutathione levels and the activity of the enzymes of glutathione metabolism in erythrocytes of patients with acute cholecystitis]. Sov Med. 1991;27-30.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Zhumadilov ZhSh, Korotkina RN, Karelin AA. [Dynamics of glutathione metabolizing enzyme activity in experimental acute cholecystitis]. Vopr Med Khim. 1991;37:42-44.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Taoka H. Experimental study on the pathogenesis of acute acalculous cholecystitis, with special reference to the roles of microcirculatory disturbances, free radicals and membrane-bound phospholipase A2. Gastroenterol Jpn. 1991;26:633-644.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Tadzhiev IIa. [The role of hyperlipoperoxidation in the development of chronic acalculous and calculous cholecystitis]. Klin Med (Mosk). 1991;69:70-74.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Zhou JF, Yan XF, Guo FZ, Sun NY, Qian ZJ, Ding DY. Effects of cigarette smoking and smoking cessation on plasma constituents and enzyme activities related to oxidative stress. Biomed Environ Sci. 2000;13:44-55.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Zhou JF, Ding DY, Guo FZ, Sun NY, Qian ZJ. Studies on correla-tions between plasma nitric oxide content, plasma lipoperoxides content and smoking. Zhejiang Yixue. 1996;18:2-4.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Zhou JF, Zhang XG, Zhong XJ. Studies on the relationship be-tween CS F-LPO, P -LPO and acute craniocerebral injury. Zhonghua Chuangshang Zazhi. 1991;7:1-4.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Zhou JF, Ding DY, Song SJ, Huang JZ, Zhang YD. Measurement of vitam in C and vitamin E concentration in cerebral infarction patients and its clinical significance. Zhejiang Yixue. 1994;16:193-195.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Zhou JF, Huang JZ, Song SJ. Measurement of plasma ascorbic acid and plas ma α -tocopherol concentration in cerebra lthrombosis patients and its clinica lsignificance. Jizhen Yixue. 1994;3:73-77.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Shanghai Medical Test Institute. Tests of medical biochemistry (Book One) .1sted. Shanghai: Shanghai Science and Technology Press. 1984;377-380.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Zhou JF, Xi GH, Huang JZ, Zhang PL. Measurement of erythrocyte lipoperoxides in certain nervous system diseases. Linchuang Shenjingbingxue Zazhi. 1992;5:5-7.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Zhou JF, Ding DY, Zhang XG. Determination of erythrocyte superoxide dismutase activity in the healthy and some patients with emergency treatment and its clinical significance. Jizhen Yixue. 1990;1:9-13.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Lei BP, Zhou BT, Cai HW, Yin CN, Tan XJ, Xu QM. Spectro-photometry of cat alase activity. Linchuang Jianyan Zazhi. 1993;11:73-75.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Zhang JL, Fang YZ. Micro determination of glutathione peroxidase activi tyin blood. Zhonghua Yixue Jianyan Zazhi. 1985;8:199-201.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Peng X, Wang SL. Nitric oxide and gastrointestinal movement. Shijie Huaren Xiaohua Zazhi. 1998;6:445-446.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Zhang Y, Ren XL. Endothelin, nitric oxide and hepatocirrhosis. Shijie Huaren Xiaohua Zazhi. 1996;4:40-41.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Huang YQ, Xiao SD, Zhang DZ, Mo JZ. Effects of nitric oxide and IL-8 on hyperdynamic circulatory state in cirrhotic patients. Shijie Huaren Xiaohua Zazhi. 1998;6:1079-1081.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Teng SL, Wu XR, Xi L. Effect of nitric oxide and free radicals on acute liver injury in rats. Shijie Huaren Xiaohua Zazhi. 1999;7:222-223.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Chen XH, Li ZZ, Bao MS, Zheng HX. Effect of nitric oxide on liver ischemia/reperfusion injury in rats in vivo. Shijie Huaren Xiaohua Zazhi. 1999;7:295-297.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Yan HM, Li YK. Research evolution on nitric oxide in chronic stomach disease. Shijie Huaren Xiaohua Zazhi. 1999;7:355-356.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Huang YQ, Wang X, Li C, Liu L. Clinical significance of nitric oxide level,esophageal pH and esophageal dynamic changes in diabetic patients. Shijie Huaren Xiaohua Zazhi. 2000;8:374-376.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Zhang ZY, Ren XL, Yao XX. Effects of endothelin and nitric oxide in hemodynamics disturbance of cirrhosis. Shijie Huaren Xiaohua Zazhi. 1998;6:588-590.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Huang YQ, Wang X, Li C, Liu L. Effect of nitric oxide on patho-genesis in patients with gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi. 2000;8:253-255.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Wang DR, Chen J, Li JM, Zhang ZG. Expression of inducible nitric oxide synthase and Hp infection in chronic gastritis and peptic ulcer. Shijie Huaren Xiaohua Zazhi. 1998;6:597-599.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Peng X, Feng JB, Wang SL. Distribution of nitric oxide synthase in stomach wall in rats. World J Gastroenterol. 1999;5:92.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Huang YQ, Xiao SD, Zhang DZ, Mo JZ. Nitric oxide synthase distribution in esophageal mucosa and hemodynamic changes in rats with cirrhosis. World J Gastroenterol. 1999;5:213-216.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Kuai XL, Ge ZJ, Meng XY, Ni RZ. Expression of nitric oxide synthase in human gastric carcinoma. Shijie Huaren Xiaohua Zazhi. 2000;8:22-24.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Wang YS, Yang JZ. Free radicals and biliary tract diseases. Shijie Huaren Xiaohua Zazhi. 1996;4:279-280.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Sun GY, Liu WW. Free radicals and digestive system neoplasms. Shijie Huaren Xiaohua Zazhi. 1998;6:272-273.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Sun GY, Liu WW, Zhou ZQ, Fang DC, Men RP, Luo YH. Free radicals in development of experimental gastric carcinoma and precancerous lesions induced by N methyl N-nitro-N-nitroso Guani-dine in rats. Shijie Huaren Xiaohua Zazhi. 1998;6:219-221.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Chen DZ, Wei MX, Gu YC, Guan XZ. Oxygen free radical harm in piyinxu and shenyinxu patients. Shijie Huaren Xiaohua Zazhi. 1998;6:660-662.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Qin RY, Zou SQ, Wu ZD, Qiu FZ. Effect of splanchnic vascular perfusion o nproduction of TNFα and OFR in rats with acute hemorrhagic necrotic pancreatit is. Shijie Huaren Xiaohua Zazhi. 1998;6:831-833.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  He L. Oxygen free radicals and digestive tract diseases. Shijie Huaren Xiaohua Zazhi. 1993;1:167-168.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Li ZL, Wu CT, Lu LR, Zhu XF, Xiong DX. Traditional Chinese medicine Qing Yi Tang alleviates oxygen free radical injury in acute necrotizing pancreatits. World J Gastroenterol. 1998;4:357-359.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Yu JC, Jiang ZM, Li DM. Glutamine: a precursor of glutathione and its effect on liver. World J Gastroenterol. 1999;5:143-146.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Li J, Tu BQ, Yang TS, Liu JJ, Jia FM. Alteration of glutathione in RBC i npatients with liver cirrhosis and its clinical significance. Shijie Huaren Xiaohua Zazhi. 1996;4:18-19.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Zheng F, Xu HB, Xiao YQ. Clinical significance of SOD measure-ment in patients with gastric carcinoma. Shijie Huaren Xiaohua Zazhi. 1999;7:101 5-1016.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Hu HQ, Lu XQ, Zhou MF. Observation of serum LPO level and RBC SOD activi ty in patients with liver cancer. Shijie Huaren Xiaohua Zazhi. 1994;2:179-180.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Sun ZJ, Wang YJ, Quan QZ, Zhang ZJ. Changes of RBC immunoadherent functi on and lipid peroxidation and effect of vitamin E in acute hepatic injury. Shijie Huaren Xiaohua Zazhi. 1996;4:6-8.  [PubMed]  [DOI]  [Cited in This Article: ]
41.  Xu XF. Significance of measurement of LPO and SOD in patients with acute pancreatitis. Shijie Huaren Xiaohua Zazhi. 1997;5:473.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Tang J. Observation of LPO level, SOD and GSH-Px activities in blood in patients with peptic ulcer. Shijie Huaren Xiaohua Zazhi. 2000;8:487-488.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Fang DC, Liu W, Liang HJ, Liu WW. Effects of Na 2SeO 3 on unscheduled DNA synthesis, lipid peroxidation and ras P21 ex-pression in gastric epithelial cells. Shijie Huaren Xiaohua Zazhi. 1998;6:421-422.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Zhou HG, Gu GW. Vitamin A compounds prevent hepatocarcinoma. Shijie Huaren Xiaohua Zazhi. 1999;7:82-83.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Wang YF, Li QF, Wang H, Mao Q, Wu CQ. Effects of vitamin E on experiment al hepatic fibrosisi in rats. Shijie Huaren Xiaohua Zazhi. 1998;6:207-209.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Zhou JF, Guo FZ, Sun NY, Qian ZJ, Ding DY. A study on the relationship between smoking and plasma nitric oxide, vitamin C, vitamin E, β -carotene con centration in elderly. Zhonghua Laonian Yixue Zazhi. 1997;16:87-89.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Zhou JF, Zhu YP, Wu DS, Peng FY, Ding DY. Study on effects of nitric oxi de and other free radicals damaging silicosis patients. Zhongguo Gonggong Weisheng. 1999;15:126-128.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Zhou J, Wu D, Zhu Y. [Changes in blood levels of nitric oxide, oxidation and lipoperoxidation in patients with silicosis]. Zhonghua Yufang Yixue Zazhi. 1998;32:333-335.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Zhou JF, Wu DS, Peng FY, Ding DY. Studies on the correlation between silicosis and nitricoxide, oxidation and lipoperoxidation. Zhonghua Laodong Weisheng Zhiyebing Zazhi. 1999;17:11-13.  [PubMed]  [DOI]  [Cited in This Article: ]
50.  Armstrong D, Sohal RS, Cutler RG, Slater TF. Free radicals in molecular biology, aging, and diseases. 1sted. New York: Raven Press. 1984;13-108.  [PubMed]  [DOI]  [Cited in This Article: ]
51.  Chen Y, Zhou M. Free radical medicine. 1st ed. Beijing: People's Milit ary Surgeon Press. 1991;223-257.  [PubMed]  [DOI]  [Cited in This Article: ]
52.  Fang YZ, Li WJ. Free radicals and enzymes. 1sted. Beijing: Science Press. 1989;147-162.  [PubMed]  [DOI]  [Cited in This Article: ]
53.  Ginsberg MD, Fietrich WD. Cerebrovascular diseases. 1st ed. New York: R aven Press. 1989;348-394.  [PubMed]  [DOI]  [Cited in This Article: ]
54.  Zhou J, Guo F, Qian Z. [Effects of cigarette smoking on antioxidant vitamin and activities of antioxidases]. Zhonghua Yufang Yixue Zazhi. 1997;31:67-70.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Zhong CS, Sun AY. Biomedicine of nitric oxide. 1st ed. Shanghai: Shanghai Medical University Press. 1997;238-249.  [PubMed]  [DOI]  [Cited in This Article: ]
56.  Zhou JF, Du YH, Wang YL, Peng FY, Ding DY. The correlation between abusi ngalcohol and antioxidants,antioxidases. Zhonghua Yufang YixueZazhi. 1998;32:303-305.  [PubMed]  [DOI]  [Cited in This Article: ]
57.  Zhou JF, Du YH, Peng FY, Ding DY. Determination of plasma concentration of antioxidant vitamins among heavy drinkers. Zhonghua Xiaohua Zazhi. 1998;18:226-228.  [PubMed]  [DOI]  [Cited in This Article: ]
58.  Zhou JF, Wang YL, Du YH, Peng FY, Ding DY. Correlation between alcohol a buse and antioxidants. Zhonghua Jingshenke Zazhi. 1998;31:34-36.  [PubMed]  [DOI]  [Cited in This Article: ]
59.  Zhou JF, Du YH, Wang YL, Peng FY, Ding DY. The correlation between abusi ng alcohol and antioxidants, antioxidases. Am J Compre Med. 1999;1:287-288.  [PubMed]  [DOI]  [Cited in This Article: ]
60.  Zhou J, Zhu Y, Wu D, Peng F, Ding D. [Study on the correlation of silicosis with antioxidant and antioxidase]. Weisheng Yanjiu. 1999;28:69-71.  [PubMed]  [DOI]  [Cited in This Article: ]
61.  Zhou JF, Liu H, Xie T. Measurement of partial antioxidation indices in multiple cerebral infarction dementia patients. Zhongguo Laonianxue Zazhi. 1995;15:266-268.  [PubMed]  [DOI]  [Cited in This Article: ]
62.  Zhou JF, Zhou KZ. A study on urinary lipid peroxide levels in pilots. Zhonghua Hangkong Yixue Zazhi. 1992;3:13-15.  [PubMed]  [DOI]  [Cited in This Article: ]
63.  Zhou JF, Zhang Y, Guo FZ. Effects of copying operation on oxidation and peroxidation of the operators. Zhonghua Laodong Weisheng Zhiyebing Zazhi. 1998;16:143-146.  [PubMed]  [DOI]  [Cited in This Article: ]
64.  Zhou JF, Wu DS, Zhu YP, Peng FY, Ding DY. The relationships of nitric ox ide, lipoperoxidation and silicosis of the elderly. Zhongguo Laonianxue Zazhi. 1999;19:340-342.  [PubMed]  [DOI]  [Cited in This Article: ]
65.  Zhou JF, Yue L, Yang JL, Gu W, Peng FY. The studies on the correlation between diabetes and nitric oxide, other free radicals injury. Am J Compre Med. 1999;1:811-813.  [PubMed]  [DOI]  [Cited in This Article: ]
66.  Zhou J, Yang J, Yue L, Gu W. [Research on nitric oxide, oxidative and lipid peroxidative parameters in blood of diabetic patients]. Weisheng Yanjiu. 1999;28:271-273.  [PubMed]  [DOI]  [Cited in This Article: ]
67.  Zhou JF. Change of free radical levels of senile angina pectoris patients. Zhongguo Laonianxue Zazhi. 1994;14:282-284.  [PubMed]  [DOI]  [Cited in This Article: ]
68.  Zhou JF, Liu QJ, Ding DY. Correlation on heroin abuse and uri-nary lipope roxides contents. Zhonghua Shenjing Jingshenke Zazhi. 1994;27:17-20.  [PubMed]  [DOI]  [Cited in This Article: ]
69.  Zhou JF, Wu DS, Zhu YP, Ding DY, Peng FY. Hemorrheological state of sili cosis patients and its clinical significance. Am J Compre Med. 2000;2:92-94.  [PubMed]  [DOI]  [Cited in This Article: ]
70.  Shvetsova MM, Zatolokin VD, Kaznacheev NN, Luk'ianchikov GF. [A method for assessing lipid peroxidation in a biological substrate]. Lab Delo. 1990;27-29.  [PubMed]  [DOI]  [Cited in This Article: ]
71.  Tsai LY, Tsai SM, Lee KT, Yu HS. Levels of plasma lipid peroxides before and after choledocholithotomy in patients with obstructive jaundice. J UOEH. 1992;14:261-269.  [PubMed]  [DOI]  [Cited in This Article: ]
72.  Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest. 1997;27:387-391.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 15]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
73.  Worthington HV, Hunt LP, McCloy RF, Maclennan I, Braganza JM. A pilot study of antioxidant intake in patients with cholesterol gallstones. Nutrition. 1997;13:118-127.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
74.  Ortega RM, Fernández-Azuela M, Encinas-Sotillos A, Andrés P, López-Sobaler AM. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr. 1997;16:88-95.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 47]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
75.  Tang WH, Han TQ, Zhang SD. Lipid metablism studies in patients with gallstones. Zhongguo Binglishengli Zazhi. 1995;11:170-173.  [PubMed]  [DOI]  [Cited in This Article: ]
76.  Xiou DR, Shen T, Fu XB, Lin C, Zhou XS. The effects of bilirubin free radical on the precipitation of human bile. Zhonghua Shiyan Waike Zazhi. 1995;12:195-197.  [PubMed]  [DOI]  [Cited in This Article: ]
77.  Liu XT, Liu HJ, Wang K. Studies on bilirubin free radical induced damag e of rat hepatocyte. Shengwuhuaxue Zazhi. 1995;11:71-75.  [PubMed]  [DOI]  [Cited in This Article: ]
78.  Liu PF, Xiao LJ, Chen JY. Primary study on dynamic changes of oxygen fre eradical in liver tissues of acute obstructive pyogenic cholangitis. Linchuang Gandanbing Zazhi. 1994;10:80-82.  [PubMed]  [DOI]  [Cited in This Article: ]